Jan Mužík

The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: An analysis of 96 allografted AML patients >= 50 years from the Czech acute leukaemia clinical register (alert)

2013 | Central Library of Charles University, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication